Search Results - "Dobrotova Miroslava"

Refine Results
  1. 1
  2. 2

    Apixaban - Metabolism, Pharmacologic Properties and Drug Interactions by Kubisz, Peter, Stanciakova, Lucia, Dobrotova, Miroslava, Samos, Matej, Mokan, Marian, Stasko, Jan

    Published in Current drug metabolism (01-01-2017)
    “…Apixaban is an oral, potent, highly selective, reversible and direct inhibitor of activated coagulation factor X, that is the end point of the intrinsic and…”
    Get more information
    Journal Article
  3. 3

    How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved? by Stanciakova, Lucia, Dobrotova, Miroslava, Holly, Pavol, Zolkova, Jana, Vadelova, Lubica, Skornova, Ingrid, Ivankova, Jela, Samos, Matej, Bolek, Tomas, Grendar, Marian, Danko, Jan, Kubisz, Peter, Stasko, Jan

    Published in Clinical and applied thrombosis/hemostasis (01-02-2022)
    “…Low-molecular-weight heparin (LMWH) is suggested for thromboprophylaxis in pregnant women with previous venous thromboembolism (VTE). Anyway, there is only…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Association of Genetic Variability in Selected Genes with Platelet Hyperaggregability and Arterial Thrombosis by Brunclikova Monika, Ivankova Jela, Skerenova, Maria, Simurda Tomas, Stanciakova Lucia, Skornova Ingrid, Sterankova Miroslava, Zolkova Jana, Dobrotova Miroslava, Pavol, Holly, Kubisz, Peter, Stasko, Jan

    Published in Acta Medica Martiniana (01-04-2022)
    “…Introduction: Inherited platelet hyperaggregability, so called “Sticky platelet syndrome” (SPS), is a prothrombotic platelet disorder. The syndrome contributes…”
    Get full text
    Journal Article
  8. 8

    Monitoring of dabigatran therapy using Hemoclot® Thrombin Inhibitor assay in patients with atrial fibrillation by Samoš, Matej, Stančiaková, Lucia, Ivanková, Jela, Staško, Ján, Kovář, František, Dobrotová, Miroslava, Galajda, Peter, Kubisz, Peter, Mokáň, Marián

    Published in Journal of thrombosis and thrombolysis (01-01-2015)
    “…Dabigatran, a new direct thrombin inhibitor, achieves strong anticoagulation that is more predictable than warfarin. Nevertheless, a patient on dabigatran…”
    Get full text
    Journal Article
  9. 9

    Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer-Single-Center Experience by Skornova, Ingrid, Simurda, Tomas, Stasko, Jan, Zolkova, Jana, Sokol, Juraj, Holly, Pavol, Dobrotova, Miroslava, Plamenova, Ivana, Hudecek, Jan, Brunclikova, Monika, Stryckova, Alena, Kubisz, Peter

    Published in Diagnostics (Basel) (20-11-2021)
    “…von Willebrand disease (VWD) is reportedly the most common inherited bleeding disorder. This disorder develops as a result of defects and/or deficiency of the…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    in vitro testing of chemoresistance in leukaemic patients by Hatok, Jozef, Tatiana MatákovÃ, Juraj Chudej, Ján StaÅ¡ko, Miroslava DobrotovÃ, DuÅ¡an Dobrota, Peter Račay

    Published in Biológia (01-02-2009)
    “…The fact that leukaemic cells are primarily or secondarily resistant to cytostatics is a serious phenomenon, which leads to the failure of chemotherapy of…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Variability of GP6 gene in patients with sticky platelet syndrome and deep venous thrombosis and/or pulmonary embolism by Kotuličová, Daniela, Chudý, Peter, Škereňová, Mária, Ivanková, Jela, Dobrotová, Miroslava, Kubisz, Peter

    Published in Blood coagulation & fibrinolysis (01-09-2012)
    “…The GP6 gene encodes the GPVI, a crucial platelet membrane glycoprotein, for adequate platelet activation, adhesion and aggregation. The objectives of the…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Congenital afibrinogenemia: from etiopathogenesis to challenging clinical management by Stanciakova, Lucia, Kubisz, Peter, Dobrotova, Miroslava, Stasko, Jan

    Published in Expert review of hematology (02-07-2016)
    “…Congenital afibrinogenemia belongs to the group of autosomal recessive bleeding disorders and represents the absolute deficiency of fibrinogen detected by an…”
    Get more information
    Journal Article
  20. 20